Rewriting the Rules on Multiple Myeloma Resistance: Ajai Chari, MDByMaggie L. Shaw,Ajai Chari, MDJune 4th 2026
CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer AdvancesByElla Hohmann, MSMay 26th 2026
The Multiple Myeloma Revolution Happening Right Now: Swarup Kumar, MDByMaggie L. Shaw,Swarup Kumar, MDMay 21st 2026
MRD Moves to Center Stage in Multiple Myeloma: Nicholas Richardson, DO, MPHByMaggie L. Shaw,Nicholas Richardson, DO, MPHMay 14th 2026